Table 5.
Quality analysis of the included studies.
| Study → | Chen et al., 2023 [13] | Tao et al., 2022 [21] | Cao et al., 2020 [31] | Chen et al., 2023 [38] | Jin et al., 2022 [39] | ||
|---|---|---|---|---|---|---|---|
| Section ↓ | Item | ||||||
| Abstract | 1 | Structured summary | Y | Y | N | Y | Y |
| Introduction | 2a | Specific background | Y | Y | Y | Y | Y |
| 2b | Specific objectives | Y | Y | Y | Y | Y | |
| Methods | 3 | Intervention | Y | Y | Y | Y | Y |
| 4 | Outcomes | Y | Y | Y | Y | Y | |
| 5 | Sample size | Y | N | N | Y | N | |
| 6 | Method for random allocation | N | N | N | Y | N | |
| 7 | Allocation concealment mechanism | N | N | N | N | N | |
| 8 | Random allocation Implementation | N | N | N | N | N | |
| 9 | Blinding | Y | Y | N | Y | N | |
| 10 | Outcome comparison methods | Y | Y | N | Y | Y | |
| Results | 11 | Outcomes and estimation | Y | Y | N | Y | Y |
| Others | 12 | Study limitations | Y | Y | Y | Y | Y |
| 13 | Funding source | Y | Y | Y | Y | Y | |
| 14 | Availability of full study protocol | Y | N | N | Y | N | |
Y = Yes; N = No.